Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4495 (MIR4495) is a short, non-coding RNA molecule classified as a microRNA, typically 20–24 nucleotides in length, involved in the post-transcriptional regulation of gene expression in multicellular organisms[1]. Like other microRNAs, MIR4495 functions by incorporating into the RNA-induced silencing complex (RISC) and binding to target mRNAs, most commonly leading to suppression of translation or mRNA destabilization. MIR4495 is not a protein-coding gene nor a conventional therapeutic target such as a receptor or an enzyme, but may regulate protein-coding genes indirectly. While many microRNAs have established disease roles or biomarker potential, there is currently no documented, specific biological role or disease association for MIR4495 in the available literature[1][3]. Its classification as a miRNA suggests it participates in diverse cellular and regulatory processes common to this RNA class.
N/A for direct pharmacological targeting (miRNAs are regulated rather than directly targeted by classic drugs; antisense oligonucleotides and similar modalities may regulate miRNA function in principle, but no drugs specifically for MIR4495 are documented)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4495 (MIR4495).